ENTYVIO

Powder for concentrate for solution for infusion, 300mg
RxActive license

Active substance (INN)

vedolizumab

Pharmaceutical form

Pharmaceutical formPowder for concentrate for solution for infusion
Strength300mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerTakeda Austria GmbH, Austria
Therapeutic groupAntineoplastic and immunomodulating agents (L04AG05)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJuly 31, 2025

Analogs in Montenegro

4

Other medicines with the same active substance

ENTYVIORx
Solution for injection in pre-filled syringe, 108mg/0.68mlTakeda Austria GmbH
ENTYVIORestricted
Solution for injection in pre-filled pen, 108mg/0.68mlTakeda Austria GmbH
ENTYVIORestricted
Solution for injection in pre-filled pen, 108mg/0.68mlTakeda Austria GmbH
ENTYVIORestricted
Solution for injection in pre-filled syringe, 108mg/0.68mlTakeda Austria GmbH
Source: CInMED register